Clopiros-AP Forte Tablet
By Clopiros-AP
Rx
10 Tablet in a Strip

Composition
Aspirin(150mg) + Clopidogrel(75mg)

Manufacturer - Maxford Labs Pvt. Ltd.
3-2-342 & 343, 2nd Floor, Chappal Bazar, Kachiguda, Hyderabad, Telangana 500027

Expires on or after
December, 2026

liver
When using Clopiros-AP Forte Tablet, it is important to exercise caution if you have liver disease. Your doctor may need to adjust the dosage accordingly. It is not advised to use Clopiros-AP Forte Tablet in cases of severe liver disease. If you have a history of liver conditions, consult your doctor before taking Clopiros-AP Forte Tablet to ensure proper guidance and dosage adjustments.

kidney
When using Clopiros-AP Forte Tablet, caution is advised for patients with kidney disease. Dose adjustment may be necessary, so consult your doctor. Avoid in cases of severe kidney disease. Follow medical advice closely.

alcohol
It is advisable to avoid drinking alcohol while taking Clopiros-AP Forte Tablet. Combining alcohol with this medication can increase the risk of stomach ulcer and gastric bleeding.

driving
Clopiros-AP Forte Tablet may decrease alertness, affect vision, or cause drowsiness and dizziness. Avoid driving if experiencing these symptoms. Clopiros-AP Forte Tablet does not impact driving ability.

pregnancy
Clopiros-AP Forte Tablet is unsafe during pregnancy, as it poses a risk to the developing baby. However, in life-threatening situations, a doctor may prescribe it if benefits outweigh risks. Consult your doctor before use.

breastfeeding
Clopiros-AP Forte Tablet should be used with caution during breastfeeding as it may pass into breastmilk and potentially harm the baby. It is advisable to consult a healthcare provider before using this medication while breastfeeding.
| Habit Forming | No |
| Chemical Class | - |
| Therapeutic Class | - |
| Action Class | - |
₹29.7
₹33
10% OFF
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 18-Nov-2024
